Global Markets for Breast Imaging and Mammography 2009

iData Research, Inc.
September 1, 2009
131 Pages - SKU: IDR2713872
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2014’, provides an overview of the Female Hypoactive Sexual Desire Disorder’s therapeutic pipeline. This report  |  read more...
USD 2,000
Uterine Cancer - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
Uterine Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Uterine Cancer - Pipeline Review, H2 2014’, provides an overview of the Uterine Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Uterine  |  read more...
USD 2,000
Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019
9/11/2014 | published by: MarketsandMarkets
Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019 The global ablation technologies market is estimated  |  read more...
USD 4,650
Hot Flashes Global Clinical Trials Review, H2, 2014
9/10/2014 | published by: GlobalData
Hot Flashes Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Hot Flashes Global Clinical Trials Review, H2, 2014 provides data on the Hot Flashes clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Metastatic Ovarian Cancer - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
Metastatic Ovarian Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Polycystic Ovarian Syndrome - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
Polycystic Ovarian Syndrome - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Polycystic Ovarian Syndrome - Pipeline Review, H2 2014’, provides an overview of the Polycystic Ovarian Syndrome’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Post Menopausal Osteoporosis - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
Post Menopausal Osteoporosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H2 2014’, provides an overview of the Post Menopausal Osteoporosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide
9/9/2014 | published by: Renub Research
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was  |  read more...
USD 1,490
Female Sexual Dysfunction - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Female Sexual Dysfunction - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Female Sexual Dysfunction - Pipeline Review, H2 2014’, provides an overview of the Female Sexual Dysfunction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014’, provides an overview of the Vaginal Atrophy (Atrophic Vaginitis)’s therapeutic pipeline. This report provides comprehensive information  |  read more...
USD 2,000
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 11,495  
    Global Site License Fulfilled by Publisher  USD 13,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!